• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The basis of allograft acceptance.

作者信息

Starzl Thomas E

机构信息

Transplantation Insititute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

出版信息

Forum (Genova). 1997;7(Suppl 6):7-18.

PMID:21572892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3092668/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/ebd3263a4e64/nihms247348f15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/6ace36dd91a3/nihms247348f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/b6a0aed5926b/nihms247348f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/18609cc6cc5c/nihms247348f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/ae0c4ad0bdb2/nihms247348f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/e8cb4eb5d2c0/nihms247348f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/3c6c98dfab8a/nihms247348f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/36c2fdc04335/nihms247348f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/5904c188e063/nihms247348f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/6ae94195d917/nihms247348f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/c5f992485ce9/nihms247348f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/38d83d136248/nihms247348f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/1b304aa2b00e/nihms247348f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/b879d31a641f/nihms247348f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/94f8170ef52e/nihms247348f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/ebd3263a4e64/nihms247348f15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/6ace36dd91a3/nihms247348f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/b6a0aed5926b/nihms247348f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/18609cc6cc5c/nihms247348f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/ae0c4ad0bdb2/nihms247348f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/e8cb4eb5d2c0/nihms247348f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/3c6c98dfab8a/nihms247348f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/36c2fdc04335/nihms247348f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/5904c188e063/nihms247348f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/6ae94195d917/nihms247348f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/c5f992485ce9/nihms247348f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/38d83d136248/nihms247348f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/1b304aa2b00e/nihms247348f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/b879d31a641f/nihms247348f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/94f8170ef52e/nihms247348f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08ad/3092668/ebd3263a4e64/nihms247348f15.jpg

相似文献

1
The basis of allograft acceptance.同种异体移植接受的基础。
Forum (Genova). 1997;7(Suppl 6):7-18.
2
Immune suppression sustained allograft acceptance requires PD1 inhibition of CD8+ T cells.维持同种异体移植物接受的免疫抑制需要PD1抑制CD8 + T细胞。
J Immunol. 2025 Jan 1;214(1):192-198. doi: 10.1093/jimmun/vkae007.
3
Transferable cardiac allograft acceptance induced by transfusion of donor B cells with impaired inducible costimulator/B7h allorecognition.通过输注诱导性共刺激分子/程序性死亡配体1同种异体识别受损的供体B细胞诱导的可移植心脏同种异体移植接受
Transplant Proc. 2009 Jun;41(5):1840-3. doi: 10.1016/j.transproceed.2009.01.106.
4
Alloantigen-driven T cell death mediated by Fas ligand and tumor necrosis factor-alpha is not essential for the induction of allograft acceptance.由Fas配体和肿瘤坏死因子-α介导的同种异体抗原驱动的T细胞死亡对于诱导同种异体移植接受并非必不可少。
Transplantation. 2000 Jun 15;69(11):2428-32. doi: 10.1097/00007890-200006150-00037.
5
Kidney allograft offers: Predictors of turndown and the impact of late organ acceptance on allograft survival.肾移植供体：拒绝接受的预测因素以及晚期器官接受对移植物存活率的影响。
Am J Transplant. 2018 Feb;18(2):391-401. doi: 10.1111/ajt.14449. Epub 2017 Sep 2.
6
Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity.同种异体移植受者的致敏模式：长期心脏同种异体移植的接受与同种异体抗体的活跃产生以及对同种异体反应性迟发型超敏反应的活跃抑制相关。
Transplantation. 1998 Apr 27;65(8):1115-23. doi: 10.1097/00007890-199804270-00017.
7
Disparities in Acceptance of Deceased Donor Kidneys Between the United States and France and Estimated Effects of Increased US Acceptance.美国和法国在接受已故捐赠者肾脏方面的差异以及美国接受率提高的估计影响。
JAMA Intern Med. 2019 Oct 1;179(10):1365-1374. doi: 10.1001/jamainternmed.2019.2322.
8
Administration of exogenous interleukin-2 abrogates spontaneous rat liver allograft acceptance but does not affect long-term established graft survival.给予外源性白细胞介素-2可消除大鼠肝脏同种异体移植的自发接受，但不影响长期建立的移植物存活。
Transplantation. 1997 Jun 15;63(11):1698-701. doi: 10.1097/00007890-199706150-00029.
9
OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade.OX40共刺激可阻止由CD40-CD40L阻断诱导的同种异体移植接受。
J Immunol. 2009 Jan 1;182(1):379-90. doi: 10.4049/jimmunol.182.1.379.
10
The development of a posttransplant TLI treatment strategy that promotes organ allograft acceptance without chronic immunosuppression.一种促进器官同种异体移植接受且无需长期免疫抑制的移植后TLI治疗策略的开发。
Transplantation. 1992 Feb;53(2):247-58. doi: 10.1097/00007890-199202010-00001.

本文引用的文献

1
IMMUNOGENETIC CONSEQUENCES OF VASCULAR ANASTOMOSES BETWEEN BOVINE TWINS.牛双胞胎之间血管吻合的免疫遗传学后果。
Science. 1945 Oct 19;102(2651):400-1. doi: 10.1126/science.102.2651.400.
2
The behaviour and fate of skin autografts and skin homografts in rabbits: A report to the War Wounds Committee of the Medical Research Council.兔自体皮肤移植和同种异体皮肤移植的行为与转归：提交给医学研究委员会战争创伤委员会的报告
J Anat. 1944 Oct;78(Pt 5):176-99.
3
Essential duration of parabiosis and development of tolerance to skin homografts in mice.小鼠联体生活的必要持续时间及对皮肤同种异体移植物耐受性的发展
Proc Soc Exp Biol Med. 1960 Jun;104:256-9. doi: 10.3181/00379727-104-25798.
4
FACTORS DETERMINING SHORT- AND LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER HOMOTRANSPLANTATION IN THE DOG.犬原位肝同种移植术后短期和长期存活的决定因素
Surgery. 1965 Jul;58:131-55.
5
HAEMATOPOIETIC CHIMERA IN MAN AFTER ALLOGENIC (HOMOLOGOUS) BONE-MARROW TRANSPLANTATION. (CONTROL OF THE SECONDARY SYNDROME. SPECIFIC TOLERANCE DUE TO THE CHIMERISM).同种异体（同源）骨髓移植后人类造血嵌合体。（继发性综合征的控制。嵌合导致的特异性耐受）
Br Med J. 1963 Dec 28;2(5373):1633-5. doi: 10.1136/bmj.2.5373.1633.
6
THE REVERSAL OF REJECTION IN HUMAN RENAL HOMOGRAFTS WITH SUBSEQUENT DEVELOPMENT OF HOMOGRAFT TOLERANCE.人类肾移植排斥反应的逆转及随后同种移植耐受性的发展
Surg Gynecol Obstet. 1963 Oct;117:385-95.
7
The homograft reaction.同种移植反应。
Annu Rev Microbiol. 1957;11:439-58. doi: 10.1146/annurev.mi.11.100157.002255.
8
The impact on the developing embryo and newborn animal of adult homologous cells.成年同源细胞对发育中胚胎和新生动物的影响。
Acta Pathol Microbiol Scand. 1957;40(6):480-500.
9
A simple method for inducing tolerance of skin homografts in mice.一种诱导小鼠皮肤同种异体移植耐受的简单方法。
Transplant Bull. 1957 Apr;4(2):67-71.
10
Mortality and skin transplantability in x-irradiated mice receiving isologous, homologous or heterologous bone marrow.接受同基因、同种异体或异种骨髓的X射线照射小鼠的死亡率及皮肤移植能力
Proc Soc Exp Biol Med. 1956 Aug-Sep;92(4):688-93. doi: 10.3181/00379727-92-22582.